Position in MIRA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$18,940
-$2,460 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 26 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MIRA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $3,769,908,119 across 17 Drug Manufacturers - General names. MIRA ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,750,788 | $2,099,947,825 | |
| 2 | ABBV |
AbbVie Inc.
|
2,151,394 | $541,376,786 | |
| 3 | JNJ |
Johnson & Johnson
|
1,943,962 | $493,708,029 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,500,619 | $192,829,541 | |
| 5 | AMGN |
Amgen Inc
|
438,431 | $158,764,633 | |
| 6 | PFE |
Pfizer Inc
|
4,509,295 | $108,583,823 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
719,424 | $90,892,028 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,140,161 | $65,696,076 |
All Filings in MIRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,940 | 20,000 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $21,400 | 20,000 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $30,200 | 20,000 | Shares | Defined | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||